Profile
ACGN VRTX VRNA REGN ALNY ARGX
Company Name Aceragen, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.24M $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.03K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO John C. Taylor Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ACGN VRTX VRNA REGN ALNY ARGX
Quant Rating Score 3 1 4 1 3
Quant Rating Neutral Strong Sell Buy Strong Sell Neutral
Trading
ACGN VRTX VRNA REGN ALNY ARGX
Last Close $0.3849 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $0.38 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $0.38 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High 1.29 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 1.29 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ACGN VRTX VRNA REGN ALNY ARGX
1 Month Return 0 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 0 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 0 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 0 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 0 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return 0 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACGN VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Profitability
ACGN VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM - 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -23.1 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM -113.18 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM -34.91 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 78.71 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 106.69 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM - 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -4374.11 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM - 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM - 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM - 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -7.52 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -7.52 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 369.9 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -4374.11 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM - 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -0.06 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -0.06 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ACGN VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.01B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.02B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -7.17 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ACGN VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.06B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.04B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.1B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ACGN VRTX VRNA REGN ALNY ARGX
Net Income $-0.02B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.7999
AARD Aardvark Therapeutics, Inc. Common Stock 11.1293
ABCL AbCellera Biologics Inc. 5.445
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.205
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.2547
ABPWW 0.0143
ABSI Absci Corporation 4.2312
ABUS Arbutus Biopharma Corporation 4.875
ABVC ABVC BioPharma, Inc. 2.84
ABVX Abivax SA American Depositary Shares 104.808
ACAD ACADIA Pharmaceuticals Inc. 22.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7774
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.195
ACIU AC Immune SA 3.465
ACLX Arcellx, Inc. 87.93
ETFs With Exposure to ACGN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.35
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.36
VXF Vanguard Extended Market Index Fund 0.00002 211.255
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00002 160.9
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00002 160.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00002 397.07
Unlock